palladium has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bejarano, I; de la Cruz-Martínez, F; Espino, J; Fernández-Delgado, E; Franco, L; Galán, C; Luna-Giles, F; Viñuelas-Zahínos, E | 1 |
| Chen, P; Tian, J; Yang, L; Yang, Y; Zhang, F; Zhang, H; Zhou, J | 1 |
2 other study(ies) available for palladium and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Pt(II) and Pd(II) complexes with a thiazoline derivative ligand: Synthesis, structural characterization, antiproliferative activity and evaluation of pro-apoptotic ability in tumor cell lines HT-29 and U-937.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cisplatin; Colonic Neoplasms; Coordination Complexes; Humans; Leukemia, Myeloid, Acute; Organometallic Compounds; Palladium; Thiazoles; Tumor Cells, Cultured | 2020 |
3-Hydroxyisoindolin-1-one derivates: Synthesis by palladium-catalyzed CH activation as BRD4 inhibitors against human acute myeloid leukemia (AML) cells.
Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Cycle Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Molecular Structure; Palladium; Phthalimides; Structure-Activity Relationship; Transcription Factors; Tumor Cells, Cultured | 2019 |